TP53 is mutated in approximately 5% of all cervical tumors according to the COSMIC online database.[29] Different patterns of TP53 mutations have been described in SCC and AC in different regions of the world, with the highest frequency of TP53 mutations occurring in AC patients in Asia.[13] However, TP53 mutations are widely scattered throughout the gene and, therefore, not suitable for analysis by the approach used here. The gene discussed is TP53; the disease is uterine cervix neoplasm.